News & AnalysisPairwise nabs $90m Series BPairwise, a gene editing platform for agriculture, has secured $90 million in Series B funding.ByIris Dorbian3 February 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsTechnologyBriefs